ArticleFrontiers in oncology2026

Case Report: Radical nephroureterectomy after toripalimab plus disitamab vedotin in biomarker-non-enriched upper tract urothelial carcinoma.

Guohui Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.